Levonorgestrel-releasing intrauterine device therapy vs oral progestin treatment for reproductive-aged patients with endometrial intraepithelial neoplasia: a systematic review and meta-analysis.

MLA

Suzuki, Yukio, et al. “Levonorgestrel-Releasing Intrauterine Device Therapy vs Oral Progestin Treatment for Reproductive-Aged Patients with Endometrial Intraepithelial Neoplasia: A Systematic Review and Meta-Analysis.” Journal of the National Cancer Institute, vol. 116, no. 5, May 2024, pp. 653–64. EBSCOhost, https://doi.org/10.1093/jnci/djae023.

APA

Suzuki, Y., Ferris, J. S., Chen, L., Dioun, S., Usseglio, J., Matsuo, K., Xu, X., Hershman, D. L., & Wright, J. D. (2024). Levonorgestrel-releasing intrauterine device therapy vs oral progestin treatment for reproductive-aged patients with endometrial intraepithelial neoplasia: a systematic review and meta-analysis. Journal of the National Cancer Institute, 116(5), 653–664. https://doi.org/10.1093/jnci/djae023

Chicago

Suzuki, Yukio, Jennifer S Ferris, Ling Chen, Shayan Dioun, John Usseglio, Koji Matsuo, Xiao Xu, Dawn L Hershman, and Jason D Wright. 2024. “Levonorgestrel-Releasing Intrauterine Device Therapy vs Oral Progestin Treatment for Reproductive-Aged Patients with Endometrial Intraepithelial Neoplasia: A Systematic Review and Meta-Analysis.” Journal of the National Cancer Institute 116 (5): 653–64. doi:10.1093/jnci/djae023.